Biologics

Severe or uncontrolled asthma during pregnancy is associated with adverse maternal and neonatal/fetal outcomes. Therefore, controlling asthma-related symptoms in women who are pregnant remains an important goal of care. There are several classes of drugs approved by the US Food and Drug Administration (FDA) for the treatment of patients with asthma, including inhaled corticosteroids, leukotriene modifiers, long-acting beta agonists, and quick-relief medications. In addition, several biologics have recently been approved for treating asthma-related symptoms. However, there remains a lack of human safety data regarding the use of these newer agents in pregnant women.

Read More ›

Subscribe to
Respiratory Practice Management

Stay up to date with respiratory news & updates by subscribing to receive the free RPM print publications or e‑Newsletter.

I'd like to recieve: